Holen Sie sich die Stockscreener-App
74.18
0.58%
-0.43
Handel nachbörslich:
74.18
Schlusskurs vom Vortag:
$74.61
Offen:
$74.61
24-Stunden-Volumen:
593.39K
Relative Volume:
0.99
Marktkapitalisierung:
$3.73B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-46.01
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
-1.79%
1M Leistung:
+42.00%
6M Leistung:
+64.04%
1J Leistung:
+77.46%
1-Tages-Spanne:
$73.26
$74.83
1-Wochen-Bereich:
$73.12
$76.02
52-Wochen-Spanne:
$36.86
$76.02
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Vergleichen Sie MIRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
74.18 | 3.73B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Fortgesetzt | Stifel | Buy |
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-04-17 | Eingeleitet | Stifel | Buy |
| 2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2021-09-20 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-12 | Eingeleitet | Citigroup | Buy |
| 2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-12 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Mirum Pharmaceuticals at Cantor Global: Financial Independence and Growth By Investing.com - Investing.com Canada
What is the next catalyst for Mirum Pharmaceuticals Inc.Trade Risk Report & Safe Capital Growth Stock Tips - khodrobank.com
Mirum Pharmaceuticals stock reaches all-time high of 75.8 USD By Investing.com - Investing.com Australia
Published on: 2025-09-04 06:58:56 - Newser
Can Mirum Pharmaceuticals Inc. benefit from deglobalization2025 Valuation Update & Weekly Market Pulse Updates - khodrobank.com
What technical models suggest about Mirum Pharmaceuticals Inc.’s comeback2025 Trade Ideas & Expert Verified Stock Movement Alerts - Newser
What indicators show strength in Mirum Pharmaceuticals Inc.2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
Using Ichimoku Cloud for Mirum Pharmaceuticals Inc. technicals2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Can Mirum Pharmaceuticals Inc. sustain its profitabilityMarket Activity Summary & Advanced Technical Signal Analysis - khodrobank.com
Mirum Pharmaceuticals stock reaches all-time high of 75.8 USD - Investing.com
Real time scanner hits for Mirum Pharmaceuticals Inc. explained2025 Short Interest & Daily Profit Focused Screening - Newser
Does Mirum Pharmaceuticals Inc. show high probability of reboundJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersEarnings Recap Report & Capital Efficient Trade Techniques - Newser
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Stock Report & Risk Controlled Swing Alerts - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Market Performance Recap & Smart Money Movement Alerts - Newser
Forecasting Mirum Pharmaceuticals Inc. price range with options dataPortfolio Gains Report & Technical Confirmation Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. impacted by rising ratesSwing Trade & Real-Time Buy Zone Alerts - khodrobank.com
Is Mirum Pharmaceuticals Inc. showing signs of accumulationMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Does Mirum Pharmaceuticals Inc. have strong fundamentalsJuly 2025 Breakouts & Risk Managed Investment Strategies - khodrobank.com
How high can Mirum Pharmaceuticals Inc. stock goEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Key Lessons & Daily Technical Forecast Reports - Newser
What are Mirum Pharmaceuticals Inc.’s earnings expectationsPortfolio Growth Summary & High Conviction Buy Zone Alerts - khodrobank.com
Strategies to average down on Mirum Pharmaceuticals Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Alagille Syndrome Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Takeda, Mirum Pharmaceuticals, Albireo - Barchart.com
How to interpret RSI for Mirum Pharmaceuticals Inc. stockQuarterly Profit Report & Real-Time Volume Analysis - Newser
What indicators show strength in Mirum Pharmaceuticals IncWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
Applying big data sentiment scoring on Mirum Pharmaceuticals Inc.July 2025 Decliners & Fast Entry Momentum Alerts - Newser
Is Mirum Pharmaceuticals Inc. stock forming a triangle pattern2025 Major Catalysts & Advanced Technical Analysis Signals - khodrobank.com
Will Mirum Pharmaceuticals Inc. benefit from seasonalityEarnings Risk Report & Capital Protection Trading Alerts - khodrobank.com
Will Mirum Pharmaceuticals Inc. stock hit new highs in YEAR2025 Volatility Report & Safe Swing Trade Setup Alerts - khodrobank.com
What is Mirum Pharmaceuticals Inc. s debt to equity ratio2025 Winners & Losers & AI Powered Buy and Sell Recommendations - khodrobank.com
What’s next for Mirum Pharmaceuticals Inc. stock pricePortfolio Profit Report & Verified Swing Trading Watchlists - Newser
Trend Dashboard Flags Mirum Pharmaceuticals Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - thegnnews.com
Can Mirum Pharmaceuticals Inc. deliver consistent dividends2025 Stock Rankings & Free Community Consensus Stock Picks - beatles.ru
Applying Elliott Wave Theory to Mirum Pharmaceuticals Inc.2025 Momentum Check & Free Community Supported Trade Ideas - Newser
Will Mirum Pharmaceuticals Inc. stock recover after recent dropInsider Buying & Expert Verified Stock Movement Alerts - Newser
Using Bollinger Bands to evaluate Mirum Pharmaceuticals Inc.2025 Winners & Losers & Long-Term Growth Plans - Newser
Mirum Pharmaceuticals Inc. Shows Risk Reward Favoring UpsideJuly 2025 Volume & Advanced Technical Signal Analysis - beatles.ru
Visual trend scoring systems applied to Mirum Pharmaceuticals Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mirum Pharmaceuticals Inc-Aktie (MIRM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Peetz Christopher | CHIEF EXECUTIVE OFFICER |
Aug 11 '25 |
Option Exercise |
2.94 |
40,000 |
117,440 |
178,641 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER |
Aug 11 '25 |
Sale |
62.00 |
40,000 |
2,480,000 |
138,641 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):